Allosteric binding of bile acids and their glycine and taurine conjugates to M1R negatively impacts the activation process, findings consistent with recent reports that M1R expression and activation inhibit colon cancer cell proliferation. The gene discussed is CHRM1; the disease is malignant colon neoplasm.